SCA
Spearhead Capital Advisors Portfolio holdings
AUM
$92.3M
1-Year Return
18.16%
This Quarter Return
+5.22%
1 Year Return
-18.16%
3 Year Return
+25.24%
5 Year Return
+54.04%
10 Year Return
–
AUM
$677M
AUM Growth
+$47.9M
(+7.6%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
2.66%
Top 10 Holdings %
Top 10 Hldgs %
30.54%
Holding
223
New
55
Increased
84
Reduced
41
Closed
38
Top Buys
| 1 |
Roper Technologies
ROP
|
$9.09M |
| 2 |
Costco
COST
|
$8.8M |
| 3 |
Consolidated Edison
ED
|
$3.24M |
| 4 |
Procter & Gamble
PG
|
$2.85M |
| 5 |
Hormel Foods
HRL
|
$2.22M |
Top Sells
| 1 |
AT&T
T
|
$9.9M |
| 2 |
Coca-Cola
KO
|
$6.3M |
| 3 |
General Dynamics
GD
|
$5.97M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$4.66M |
| 5 |
Vanguard Small-Cap Growth ETF
VBK
|
$4.25M |
Sector Composition
| 1 | Technology | 14.06% |
| 2 | Healthcare | 12.64% |
| 3 | Consumer Staples | 11.38% |
| 4 | Financials | 9.76% |
| 5 | Communication Services | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sarepta Therapeutics
SRPT
$1.93B
| $321K | 0.05% |
4,312
+2,370
| +122% | +$176K |
|
|
NVTA
152
DELISTED
Invitae Corporation
NVTA
| $321K | 0.05% |
8,405
-4,172
| -33% | -$159K |
|
153
Beyond Meat
BYND
$180M
| $318K | 0.05% |
+2,446
| New | +$318K |
|
154
Celsius Holdings
CELH
$15.7B
| $318K | 0.05% |
+19,881
| New | +$318K |
|
155
Quanterix
QTRX
$201M
| $318K | 0.05% |
+5,435
| New | +$318K |
|
|
PLAN
156
DELISTED
Anaplan, Inc.
PLAN
| $318K | 0.05% |
5,909
+1,095
| +23% | +$58.9K |
|
157
Ultragenyx Pharmaceutical
RARE
$3.01B
| $315K | 0.05% |
+2,768
| New | +$315K |
|
158
lululemon athletica
LULU
$24.7B
| $314K | 0.05% |
1,023
+72
| +8% | +$22.1K |
|
159
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $313K | 0.05% |
+21,429
| New | +$313K |
|
160
iShares ESG Aware MSCI EM ETF
ESGE
$5.09B
| $312K | 0.05% |
7,213
| – | – |
|
161
Roku
ROKU
$14.3B
| $311K | 0.05% |
955
-869
| -48% | -$283K |
|
162
Twist Bioscience
TWST
$1.55B
| $311K | 0.05% |
+2,507
| New | +$311K |
|
163
CryoPort
CYRX
$443M
| $309K | 0.05% |
+5,938
| New | +$309K |
|
164
PTC Therapeutics
PTCT
$4.61B
| $308K | 0.05% |
+6,499
| New | +$308K |
|
165
Regenxbio
RGNX
$498M
| $307K | 0.05% |
+9,008
| New | +$307K |
|
166
Vanguard Long-Term Treasury ETF
VGLT
$9.9B
| $300K | 0.04% |
3,627
+1,077
| +42% | +$89.1K |
|
167
Tenable Holdings
TENB
$3.68B
| $299K | 0.04% |
+8,270
| New | +$299K |
|
168
Vanguard Long-Term Corporate Bond ETF
VCLT
$6.77B
| $298K | 0.04% |
2,939
+467
| +19% | +$47.4K |
|
169
Elastic
ESTC
$9B
| $287K | 0.04% |
+2,585
| New | +$287K |
|
170
Karyopharm Therapeutics
KPTI
$58.4M
| $284K | 0.04% |
+1,802
| New | +$284K |
|
171
Illumina
ILMN
$15.5B
| $281K | 0.04% |
752
+25
| +3% | +$9.34K |
|
172
NextEra Energy, Inc.
NEE
$146B
| $277K | 0.04% |
3,666
+242
| +7% | +$18.3K |
|
173
iRhythm Technologies
IRTC
$5.85B
| $275K | 0.04% |
1,979
-631
| -24% | -$87.7K |
|
174
Vanguard Real Estate ETF
VNQ
$34.3B
| $275K | 0.04% |
2,998
+423
| +16% | +$38.8K |
|
175
LiveRamp
RAMP
$1.82B
| $271K | 0.04% |
+5,219
| New | +$271K |
|